NAD+: A Research Overview

All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.

NAD+ (nicotinamide adenine dinucleotide) is a molecule central to cellular energy metabolism and redox biology, present in every living cell. It is heavily discussed in longevity and wellness communities, and it is one of the few compounds on this page with a meaningful, if still early, human clinical research base. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This page summarizes what the published research actually shows.

What NAD+ Is

NAD+ is a coenzyme, a helper molecule that many enzymes throughout the body depend on to carry out chemical reactions related to energy production and cellular repair. Researchers commonly study it alongside its precursors, molecules the body can convert into NAD+, most often nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Any NAD+ material supplied by BioRegen is handled strictly as a lab chemical for laboratory and educational research, not for use in people or animals.

What the Research Shows

NAD+ and its precursors have been studied in early human trials examining safety and metabolic and aging biomarkers; results on hard clinical outcomes remain early and mixed. A 2026 PRISMA-guided systematic review of preclinical and clinical evidence for NAD+ supplementation in anti-aging and wellness contexts found that oral precursors reliably raise NAD-related biomarkers in humans, with NMN and NR each shown to roughly double circulating NAD+ levels after a period of supplementation, while effects on metabolic, vascular, and performance outcomes were described as mixed, and evidence for clinically meaningful anti-aging or wellness benefit as heterogeneous and inconclusive across outcome domains. A 2022 randomized, double-blind, placebo-controlled safety trial of oral NMN in healthy adult men and women found it generally well tolerated over the trial period at the doses studied. NAD+ itself is also central to cellular energy metabolism and redox biology in a large body of separate preclinical work linking its availability to mitochondrial function and aging pathways in cell and animal models.

Community Discussion and Its Limits

NAD+ is heavily discussed in longevity and wellness communities, often in connection with IV administration or oral supplement use. That discussion is unverified anecdotal commentary, not controlled data, and not a BioRegen claim. NAD+ is somewhat unusual among the compounds discussed on this site in that a real, if still early and mixed, human trial literature exists; readers should still weigh community discussion of specific outcomes separately from what the controlled trials have actually shown.

Regulatory Status and Handling

NAD+ is sold in some jurisdictions as a dietary supplement or compounded preparation; NAD+ itself is not an FDA-approved drug. BioRegen supplies NAD+ reference material strictly for laboratory and educational research, not for human use. As a lab chemical, it is typically supplied as a lyophilized (freeze-dried) powder that should be kept cold and reconstituted only immediately before use in a laboratory setting. For a general, lab-level overview of how researchers prepare peptides and related compounds, see our overview on how to reconstitute peptides. These notes cover laboratory handling only and are not directions for use in people or animals.

Frequently Asked Questions

Does NAD+ have human clinical trial data?

Yes, more than most compounds discussed on this site, though results remain early and mixed. Trials of NAD+ precursors like NMN and NR have examined safety and biomarker effects in humans, with a 2026 systematic review finding reliable biomarker changes but heterogeneous and inconclusive results on clinically meaningful outcomes.

What is the difference between NAD+ and NMN or NR?

NMN and NR are precursor molecules the body can convert into NAD+. Most human trials study these precursors directly rather than NAD+ itself, since they are more commonly used in oral research and supplement contexts.

Is NAD+ approved for any use in people?

NAD+ itself is not an FDA-approved drug, though it and its precursors are sold in some jurisdictions as dietary supplements or compounded preparations. The material BioRegen supplies is a lab chemical intended strictly for laboratory and educational research.

Continue Your Research

To explore related compounds, use our research finder or browse the metabolic and energy research category. New to sourcing reference materials? Read the BioRegen research guide and create a free account for 10% off your first order.

Selected research references

• NAD+ Supplementation for Anti-Aging and Wellness: A PRISMA-Guided Systematic Review of Preclinical and Clinical Evidence. Ageing Research Reviews, 2026.
• Safety Evaluation of β-Nicotinamide Mononucleotide Oral Administration in Healthy Adult Men and Women. Scientific Reports, 2022.

Reference metadata sourced via Crossref.

All information on this page is provided strictly for laboratory and educational research purposes. No compound referenced is approved for human or veterinary use, none of it is intended to diagnose, treat, cure, or prevent any disease, and nothing here constitutes medical advice.